Science 37’s flexible Science 37 Certified program provides contract research organizations (CROs) with direct access to its Operating System to enable decentralized trial solutions.   LOS ANGELES, January 21, 2021 — Science 37, the industry leader in decentralized clinical trials, today announced a premier partnership program, Science 37 Certified, designed to empower CROs with access, training, and commercial support required to successfully deliver decentralized clinical studies for pharmaceutical sponsors. This collaborative program leverages Science 37’s best-in-class…

Science 37 and Signant Health have announced a partnership to strengthen capabilities for decentralized or virtual CNS clinical research. By bringing research to patients at home, the partnership will ease the participation burden typical of a traditional study, and with CNS as the second largest therapeutic area in clinical research, the partnership also will enable crucial telepsychiatry services for the growing therapeutic market.

Science 37 is excited to be part of the first-of-its-kind direct-to-family study with the Duke Clinical Research Institute (DCRI) for decentralized research in pediatric lupus. The iPERSONAL (Individual Patient Exposure and Response in Pediatric Lupus) study will help determine the most effective dose of hydroxychloroquine for children and teens with lupus as well as whether a digital pill bottle aids medication adherence. As the world continues to adapt to the global COVID-19 pandemic, the study…

Patients using Science 37’s technology platform can now connect their health record directly, in real time—eliminating paper documentation and streamlining information sharing.   LOS ANGELES, September 10, 2020 — Science 37, the industry leader in decentralized clinical trials, today launched an electronic health record (EHR) integration feature for more than 10,000 health facilities and 280 million U.S. patients. With this connection, patients using Science 37’s best-in-class technology platform can easily authorize and share their health record…

Technology partnership enables trial sponsors to improve imaging, respiratory, and cardiac safety data quality while reducing patient burden and risk.   PHILADELPHIA & LOS ANGELES, August 25, 2020 —  ERT, the global leader in clinical endpoint data collection and Science 37, the leader in decentralized clinical trials, today announced a partnership enabling ERT’s Cardiac Safety, Respiratory, and Imaging solutions to be incorporated into the Science 37 virtual, or decentralized clinical trial offering. The combined solution…